United States: In The First Case Of Its Kind, Court Rules Federal Law Does Not Trump Employee Protections Under State Medical Marijuana Law

Last Updated: August 21 2017
Article by Matthew Curtin, Dale L. Deitchler and Elizabeth R. McKenna

Employers nationwide take note: if your workplace drug and alcohol-testing policies take a zero tolerance approach to medical marijuana because the use, distribution, or possession of marijuana is unlawful under federal law, a recent federal court decision interpreting state law could be a game-changer. On August 8, 2017, in Noffsinger v. SSC Niantic Operating Company LLC, d/b/a Bride Brook Nursing & Rehabilitation Center, a Connecticut federal district court held that various federal laws prohibiting use and sale of marijuana do not preempt Connecticut's Palliative Use of Marijuana Act (PUMA), which protects employees and job applicants from employment discrimination based on medical marijuana use permitted under state law. The core implication of the Noffsinger decision is that federal law does not prohibit employment of illegal drug users. The decision is also the first to imply a private cause of action under PUMA's employment anti-discrimination provisions.

Plaintiff's PTSD, Failed Drug Test, and PUMA Claim

The plaintiff claimed she was diagnosed with post-traumatic stress disorder (PTSD) and that as a result, her doctors recommended she use medical marijuana. She registered with the Connecticut Department of Consumer Protection, and following registration, began using Marinol, a synthetic form of marijuana.

The defendant recruited the plaintiff in 2016, extending an employment offer contingent on plaintiff's passing a pre-employment drug test. The plaintiff notified the employer that she was a registered medical marijuana user who took Marinol, but only at night before bed so she would not be impaired at work. The plaintiff then took the pre-employment drug test.

The day before the plaintiff was scheduled to start work, the drug-testing company informed the parties that the plaintiff had tested positive for cannabis. That same day, the defendant rescinded the plaintiff's job offer because of the failed drug test.

The plaintiff sued, alleging the defendant violated PUMA's anti-discrimination provision. The defendant moved to dismiss, primarily asserting plaintiff's PUMA claim was preempted by three federal statutes: the Controlled Substances Act (CSA), the Americans with Disabilities Act (ADA), and the Food, Drug, and Cosmetic Act (FDCA).

Court Rules Federal Law Does Not Prohibit Employing Illegal Drug Users and Implies Private Cause of Action under PUMA

The Noffsinger court found no federal preemption of PUMA. The court first analyzed the CSA, the federal statute criminalizing marijuana use. While the court recognized that PUMA affirmatively authorizes the very conduct the CSA expressly prohibits—i.e., marijuana use—this conflict was not enough to support a conclusion that PUMA is an obstacle to CSA's goals. While the court recognized that the CSA prohibits marijuana use, the court noted that the CSA does not prohibit employing marijuana users, nor does it seek to regulate employment practices at all. For this reason, the court concluded that the CSA did not prevent the plaintiff from making a claim based on PUMA's prohibition on "an employer . . . taking adverse action against an employee on the basis of the employee's otherwise state-authorized medicinal use of marijuana."

The court reached the same conclusion under the ADA. Initially, the court stressed that the ADA's primary purpose is to protect employees from discrimination, a purpose shared under PUMA's anti-discrimination provision. The court then explained that while the ADA explicitly allows employers to prohibit illegal drug use at the workplace, it does not authorize employers to take adverse employment action based on illegal drug use outside of the workplace. Accordingly, the court found that the ADA does not preempt PUMA's medical marijuana anti-discrimination provision. Notably, the court also specifically rejected the argument that employers can universally use a negative drug-test result as a qualification standard for employment.

Finally, the court concluded the FDCA—the statute that authorizes the federal Food and Drug Administration to oversee the safety of food, drugs and cosmetics—did not preempt PUMA. Although the court recognized that PUMA permits drug use that the Food and Drug Administration has not approved, the court once again adopted a narrow view of federal law, finding the FDCA does not regulate employment. As a result, PUMA's anti-discrimination provision, the court ruled, did not conflict with or pose an obstacle to FDCA goals.

The court then held—again on an issue of first impression—that an implied private right of action exists under the PUMA's anti-discrimination prohibition (PUMA does not contain an explicit private cause of action) for an employer's adverse employment actions taken based on rights protected by PUMA. The Noffsinger court reasoned that without a private cause of action, PUMA, "would have no practical effect, because the law does not provide for any other enforcement mechanism."

The Court Failed to Address the Legality of Marinol Use Under Federal Law

The Noffisinger decision is somewhat odd because Marinol (or dronabinol) is lawful under the CSA – it is a CSA Schedule III drug that can be prescribed and used without violating the CSA.1 Thus, the very conduct forming the basis for plaintiff's state-law discrimination claim was potentially also actionable under the ADA, but neither the parties nor the court addressed this issue. For this reason alone the decision may be of limited value in future cases where an applicant or employee's drug use is in fact prohibited by federal law.

Employer Takeaways

Noffsinger is significant because it is the first decision to conclude that marijuana's unlawful status under federal law does not bar a discrimination claim based on conduct protected by state medical marijuana laws. While the decision specifically concerns PUMA, its conclusion may have far-reaching consequences that can substantially change the playing field for employers, including employers that operate in the growing number of states that also provide affirmative employment protections for medical marijuana users.

Many years ago, the United States Supreme Court ruled that both medical marijuana growers and users could be prosecuted under the CSA.2 Additionally, seven years ago, the Oregon Supreme Court expressly held that the CSA preempts the Oregon Medical Marijuana Act.3

Thus, until Noffsinger, employers could generally—without contrary authority—reasonably argue that the federal CSA, which criminalizes marijuana, preempts state medical marijuana laws. This allowed employers to enforce a drug-testing policy under which all applicants and employees were subject to adverse action for positive test results because marijuana remained illegal as a matter of federal law.4 So long as the policy was applied uniformly, the employer could take the position that it was not taking action against an employee due to the employee's status as a medical marijuana user, but, rather, was simply enforcing a policy applicable to all employees with respect to drugs that are illegal under federal law. Noffsinger arguably invalidates that approach under Connecticut law, and courts in other jurisdictions with similar medical marijuana statutes might follow this lead.

As noted above, Noffsinger also is significant because the court concluded that there is a private cause of action for violations of the PUMA discrimination provision. By recognizing an implied cause of action, the decision could increase the potential for litigation in other states with medical marijuana laws without an express statutory enforcement mechanism.

The Noffsinger decision is not binding on other courts, but an appeal to the United States Court of Appeals for the Second Circuit is likely. As the first decision of its kind, there is risk that other courts may decide the reasoning of the decision is persuasive, particularly in states with robust medical marijuana laws that provide affirmative anti-discrimination and other employment protections. It bears emphasis that Noffsinger is the second significant decision this summer to assess the employment impact of a state law permitting the use of medical marijuana. In Barbuto v. Advantage Sales & Marketing, LLC, SJC-12226, the Massachusetts Supreme Judicial Court determined that an employer has obligations to accommodate lawful medical marijuana users under Massachusetts disability discrimination laws. Barbuto and Noffsinger may signal a new trend expanding the protections that must be afforded to employees who use medical marijuana under state law.


1 21 C.F.R. § 1308.13 (g).

United States v. Oakland Cannabis Buyers Co-Op, 532 U.S. 483 (2001) (growers can be prosecuted); Gonzales v. Raich, 545 U.S. 1 (2005) (users can be prosecuted).

Emerald Steel Fabricators, Inc. v. Bureau of Labor and Industries, 348 Or. 159 (2010).  See also Christopher Leh, Oregon Supreme Court Decides Employers Not Required to Accommodate an Employee's Use of Medical Marijuana, Littler ASAP (May 3, 2010).  The employer in Noffisinger does not appear to have argued, like the employer in Emerald Steel, that the state medical marijuana law in its entirety was preempted.

4 In the recent decision in Barbuto v. Advantage Sales and Marketing, SJC-12226 (Mass. July 17, 2017), in which the Supreme Judicial Court of Massachusetts recognized a state disability law claim brought by an medical marijuana using applicant, the employer had waived federal preemption defenses   See Christopher B. Kaczmarek, Nancy Delogu, and Richard Marks, Massachusetts Supreme Judicial Court Creates Employer Obligation to Accommodate Employees Using Medical Marijuana, Littler Insight (July 19, 2017).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Wilson Elser Moskowitz Edelman & Dicker LLP
Wilson Elser Moskowitz Edelman & Dicker LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Wilson Elser Moskowitz Edelman & Dicker LLP
Wilson Elser Moskowitz Edelman & Dicker LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions